Lim V Y T, Lim Y L
Division of Cardiology, Changi General Hospital, 2 Simei Street 3, Singapore 529889.
Singapore Med J. 2003 Sep;44(9):482-7.
The long-term success of percutaneous coronary intervention in the treatment of coronary artery disease is hampered by the occurrence of restenosis, which often necessitates repeat hospitalisations or coronary interventions. The advent of drug-eluting stents, particularly those coated with sirolimus and paclitaxel, may be the breakthrough in the battle against restenosis that interventional cardiologists have been waiting for, and we review the currently available evidence for this. Despite the growing enthusiasm, we should not forget that this new technology is still in its relative infancy, and there remain many unanswered questions, particularly about the long-term effect of using these stents.
经皮冠状动脉介入治疗冠心病的长期成功受到再狭窄发生的阻碍，而再狭窄常常需要再次住院或进行冠状动脉介入治疗。药物洗脱支架的出现，尤其是那些涂有西罗莫司和紫杉醇的支架，可能是介入心脏病学家一直在等待的对抗再狭窄的突破，我们对此回顾目前可得的证据。尽管热情日益高涨，但我们不应忘记这项新技术仍处于相对初期阶段，仍有许多未解决的问题，尤其是关于使用这些支架的长期影响。
